Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this?

Massimo Martinoa Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Grande Ospedale Metropolitano “Bianchi-Melacrino-Morelli”, Reggio Calabria, ItalyCorrespondence[email protected] [email protected]

https://orcid.org/0000-0002-3987-419X View further author information

Barbara Gamberib Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Reggio Emilia, ItalyView further author information

Elisabetta Antoniolic Hematology Department, Careggi Hospital, Florence, ItalyView further author information

Sara Aquinod Hematology and Hematopoietic Stem Cell Transplantation Unit, IRCCS Ospedale Policlinico San Martino, Genoa, ItalyView further author information

Roberta Della Pepae Hematology Unit, Department of Clinical Medicine and Surgery, University of Naples “Federico II”, Naples, ItalyView further author information

Lara Malerbaf Haematology and Haematopoietic Stem Cell Transplant Center, AST, Pesaro Urbino, Pesaro, ItalyView further author information

Silvia Mangiacavallig Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyView further author information

Sara Pezzattih Department of Haematology, San Gerardo Hospital, Monza, MB, ItalyView further author information

Sara Bringheni SSD Clinical trial in oncoematologia e mieloma multiplo, Dipartimento di Oncologia, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy

https://orcid.org/0000-0003-4539-6363 View further author information

Elena Zamagnij IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy;k Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, ItalyView further author information

show all

Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this?

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this?

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date